BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28226391)

  • 21. Short notes on maximum likelihood inference for control-based pattern-mixture models.
    Tang Y
    Pharm Stat; 2015; 14(5):395-9. PubMed ID: 26178475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Covariate adjustment in randomized trials with binary outcomes: targeted maximum likelihood estimation.
    Moore KL; van der Laan MJ
    Stat Med; 2009 Jan; 28(1):39-64. PubMed ID: 18985634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison via simulation of least squares Lehmann-Scheffé estimators of two variances and heritability with those of restricted maximum likelihood.
    Slanger WD; Carlson JK
    J Anim Sci; 2003 Aug; 81(8):1950-8. PubMed ID: 12926777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size for a two-group comparison of repeated binary measurements using GEE.
    Jung SH; Ahn CW
    Stat Med; 2005 Sep; 24(17):2583-96. PubMed ID: 16118812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Power and sample size for the S:T repeated measures design combined with a linear mixed-effects model allowing for missing data.
    Tango T
    J Biopharm Stat; 2017; 27(6):963-974. PubMed ID: 28319460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An analytic method for the placebo-based pattern-mixture model.
    Lu K
    Stat Med; 2014 Mar; 33(7):1134-45. PubMed ID: 24122822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
    Friede T; Kieser M
    Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sample size estimation for GEE method for comparing slopes in repeated measurements data.
    Jung SH; Ahn C
    Stat Med; 2003 Apr; 22(8):1305-15. PubMed ID: 12687656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On statistical tests for homogeneity of two bivariate zero-inflated Poisson populations.
    Yuen HK; Chow SC; Tse SK
    J Biopharm Stat; 2015; 25(1):44-53. PubMed ID: 24837140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses should be reserved as secondary analyses.
    Collister D; Bangdiwala S; Walsh M; Mian R; Lee SF; Furukawa TA; Guyatt G
    J Clin Epidemiol; 2021 Jun; 134():95-102. PubMed ID: 33561528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple hybrid variance estimator for the Kaplan-Meier survival function.
    Borkowf CB
    Stat Med; 2005 Mar; 24(6):827-51. PubMed ID: 15558837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Instrumental variable with competing risk model.
    Zheng C; Dai R; Hari PN; Zhang MJ
    Stat Med; 2017 Apr; 36(8):1240-1255. PubMed ID: 28064466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and analysis of three-arm trials with negative binomially distributed endpoints.
    Mütze T; Munk A; Friede T
    Stat Med; 2016 Feb; 35(4):505-21. PubMed ID: 26388314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation Methods for Mixed Logistic Models with Few Clusters.
    McNeish D
    Multivariate Behav Res; 2016; 51(6):790-804. PubMed ID: 27802068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small sample inference for fixed effects from restricted maximum likelihood.
    Kenward MG; Roger JH
    Biometrics; 1997 Sep; 53(3):983-97. PubMed ID: 9333350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cox regression with missing covariate data using a modified partial likelihood method.
    Martinussen T; Holst KK; Scheike TH
    Lifetime Data Anal; 2016 Oct; 22(4):570-88. PubMed ID: 26493471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An application of the mixed-effects model and pattern mixture model to treatment groups with differential missingness suspected not-missing-at-random.
    Gosho M; Maruo K
    Pharm Stat; 2021 Jan; 20(1):93-108. PubMed ID: 33249763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-response models for the analysis of non-monotone ignorable missing data.
    Robins JM; Gill RD
    Stat Med; 1997 Jan 15-Feb 15; 16(1-3):39-56. PubMed ID: 9004382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.